India Ready to Battle COVID-19 Logistical Challenge? Vaccinization Updates.

January 1, 2021

Several vaccines are under development and the whole wide world has long awaited a fully functional vaccine to combat the much prolonged COVID-19 pandemic. While India may start mass vaccination against Coronavirus before February 2021, vaccinating a population of 1.3 billion is going to be a logistical challenge waiting to test the country's capabilities. However, when it comes to immunization, India is a powerhouse and there's no scarcity of confidence which is demonstrated in a notably "slowed-down" contagion. The ambition is further bolstered by India's reputation for reaching enormous targets. The best way to prevent contagion is quarantine, however, following directions, monitoring health, and isolation from people can only ensure as much safety. Modern Comforts provide a wide variety of Health and Sanitization products to help lessen the spread of the disease more effectively as battling this health crisis out is our joint responsibility. Modern remains committed to serve the country by safely delivering sanitization products all across the nation. Here are the various products offered by Modern Comforts – Automatic Sanitizer Dispenser, UVC Shoe Sole Sterilizer, Modern Humidifier Fogging Machine, and iSmart UVC, to name a few. Here's the link to shop all your safety equipment at one place
Here are some of the main vaccines on which Indians have their hopes pinned:

1) Covaxin
Developed by Bharat Biotech’s Bio-Safety Level 3 (BSL-3) bio-containment facility in Hyderabad, in coalition with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV), Covaxin is India's indigenous Coronavirus vaccine that is expected to be launched around February 2021. The vaccine received approval from the Drugs Controller General of India (DGCI) in July 2020 for conducting Phase I and Phase II trials which witnessed participation from 1,000 candidates, approximately. Whereas, the Phase III trials that are being held at Ahmedabad, in Gujarat recorded cold responses from volunteers in various parts of the country.

2) Oxford - AstraZeneca Vaccine
AstraZeneca is another vaccine eagerly anticipated for its chief executive's claim of promising results, the vaccine has earned a reputation for being "100% effective against the COVID-19 disease". It has been manufactured by the British drugs group AstraZeneca, jointly with the University of Oxford and is being currently examined by Britain's independent medicines regulator, and is expected to be approved in upcoming days. As per the trial outcomes, the manufacturer received a vaccine efficacy equivalent to that of Pfizer-BioNTech and Moderna, at 95% and 94.5%, respectively.

3) Zydus Cadila's ZyCoV-D
Ahmedabad based Pharmaceutical major, Zydus Cadila is expected to enter phase III clinical trials for its COVID-19 vaccine ZyCoV-D which is likely to be launched by March 2021. After its Phase I and Phase II clinical trials, ZyCoV-D has achieved the status of "immunogenic, well-tolerated and safe." However, no finals comments can be made till the trails are underway.